Clinical study on improving postoperative symptoms of cervical spondylotic myelopathy by Qishe pill
Phase 4
Recruiting
- Conditions
- Cervical spondylotic myelopathy
- Registration Number
- ITMCTR1900002834
- Lead Sponsor
- onghua Hospital Shanghai University of Traditional Chinese Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- Not specified
Inclusion Criteria
1. Meet the diagnostic criteria;
2. The patients were aged between 18 and 80 years.
3. Cervical spondylotic myelopathy patients receiving surgical treatment (including anterior and posterior);
4. Signed Informed consent.
Exclusion Criteria
1. Women who are nursing or preparing for pregnancy;
2. Patients with liver, kidney, hematopoietic system, endocrine system and other serious primary diseases and mental diseases;
3. Patients with other spinal diseases, tumors, cerebral infarction, etc. that affect limb sensation and function;
4. A suspected history of alcohol or drug abuse, or, in judgment, a reduced likelihood of inclusion or admission;
5. Subjects who are participating in other drug clinical studies.
Study & Design
- Study Type
- Interventional study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method JOA;NDI;VAS;
- Secondary Outcome Measures
Name Time Method